Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Primary & Preventive Care

Why an anemia chart is the ultimate diagnostic tool for primary care and functional medicine

Key Takeaways

Key Takeaways

An anemia chart is a diagnostic reference tool that classifies anemia into microcytic, normocytic, and macrocytic categories based on MCV, RDW, and hemoglobin levels.

WHO defines anemia as hemoglobin <13 g/dL in adult males and <12 g/dL in non-pregnant adult females; normal RDW ranges from 11.5% to 14.5%.

Key differentiators include serum ferritin, TIBC, reticulocyte count, and peripheral blood smear findings that help distinguish iron deficiency from B12/folate deficiency and chronic disease anemia.

Pabau’s digital forms and clinical documentation features help practitioners capture, store, and track anemia workup findings in organized patient records.

Download your free anemia chart

Anemia Chart

A comprehensive diagnostic reference covering morphologic classification (microcytic, normocytic, macrocytic), hemoglobin severity thresholds, lab value interpretation (MCV, RDW, ferritin, TIBC, reticulocyte count), WHO diagnostic criteria, and stepwise differential diagnosis pathways for clinical practice.

Download template

What is an anemia chart?

An anemia chart is a clinician-ready diagnostic reference tool that helps healthcare practitioners systematically classify, evaluate, and manage patients with suspected or confirmed anemia. The tool consolidates morphologic classification (microcytic, normocytic, macrocytic), WHO hemoglobin severity thresholds, and key laboratory markers—MCV, RDW, serum ferritin, TIBC, reticulocyte count, and peripheral smear findings—into a single visual guide. Unlike generic reference materials, a practice-focused anemia chart bridges the gap between laboratory results and clinical decision-making, enabling rapid differential diagnosis and tailored workup prioritization.

Anemia affects an estimated 9.3% of the US population ages 2 and older, with prevalence higher in females (13.0%) than males (5.5%), according to CDC NCHS data from August 2021-August 2023. Clinicians require quick reference tools that connect hemoglobin levels to severity grading and clinical features—something an organized anemia chart delivers in seconds, reducing diagnostic delays and supporting understanding biomarkers and lab findings within a structured framework.

The chart serves three immediate purposes: first, it confirms WHO diagnostic thresholds for anemia (hemoglobin <13 g/dL in adult males, <12 g/dL in non-pregnant females); second, it maps morphologic findings (low MCV, normal MCV, high MCV) to probable etiologies; and third, it guides next-step testing based on reticulocyte count and iron metabolism markers.

How to use the chart

A well-designed anemia chart follows a stepwise diagnostic logic that mirrors real practice workflows. The five-step pathway below guides practitioners from initial presentation through differential diagnosis confirmation.

  1. Step 1: Measure hemoglobin and MCV —Start with a complete blood count (CBC) with differential. Record the hemoglobin level and mean corpuscular volume (MCV). Cross-reference the hemoglobin against WHO thresholds printed on the chart to confirm anemia status and severity grade (mild, moderate, severe).
  2. Step 2: Classify by MCV category —Plot the MCV result into the appropriate morphologic category: microcytic (MCV <80 fL), normocytic (MCV 80-100 fL), or macrocytic (MCV >100 fL). The chart should display differential diagnoses for each category to narrow the field immediately.
  3. Step 3: Check reticulocyte count and RDW —The reticulocyte count indicates bone marrow response to anemia. Elevated reticulocytes suggest hemolysis or acute bleeding; low reticulocytes point to production defects (iron, B12, folate) or chronic disease. RDW (normal 11.5-14.5%) helps detect mixed causes—elevated RDW alongside normal MCV may suggest early iron deficiency or mixed iron/B12 deficiency.
  4. Step 4: Measure iron metabolism markers —For microcytic anemia, obtain serum ferritin, TIBC (total iron-binding capacity), and serum iron to assess iron stores. Low ferritin (<15 ng/mL) with elevated TIBC confirms iron deficiency; normal ferritin in a microcytic patient suggests thalassemia trait or chronic disease. This step differentiates iron deficiency from anemia of chronic disease (AOCD), which presents with low iron but low TIBC and preserved or elevated ferritin.
  5. Step 5: Order targeted tests and document findings —Use clinical documentation best practices to record all findings in the patient record. For suspected B12/folate deficiency, order serum B12 and folate levels; for hemolytic anemia, obtain haptoglobin and LDH; for AOCD, measure EPO levels. Link each result to the morphologic category and next-step treatment decision on the chart.

An effective anemia chart consolidates these five steps into a single reference—eliminating back-and-forth flipping through multiple resources and reducing the risk of missed differential diagnoses.

See how Pabau organizes clinical workflows

Discover how practitioners use Pabau's structured forms and clinical documentation to capture comprehensive anemia workup findings, enabling faster diagnosis and better patient outcomes.

Pabau practice management interface

Who benefits most?

An anemia chart is essential for any healthcare setting where practitioners evaluate patients with suspected blood disorders or chronic conditions that commonly present with anemia.

  • Primary care physicians and general practitioners who screen for anemia as part of routine wellness exams or when patients present with fatigue, pallor, or dyspnea. Private GPs rely on quick diagnostic references to decide whether to manage anemia in-office or refer to hematology.
  • Nurse practitioners and physician assistants in independent or collaborative practice who conduct initial patient evaluations and require evidence-based triage tools to support clinical decision-making and improving patient understanding and compliance with recommended testing.
  • Functional and integrative medicine practitioners who assess micronutrient status and anemia risk in wellness-focused populations. Many functional practices use anemia charts to connect subclinical iron or B12 findings to symptom resolution.
  • Hematology-focused practices and medical spas that incorporate blood work interpretation into pre-treatment assessment protocols for IV therapy, regenerative medicine, or longevity programs. An organized anemia chart ensures all practitioners apply consistent diagnostic criteria.
  • Medical directors and nurse supervisors in multi-location or franchised practices who standardize diagnostic protocols across teams. Distributing a shared anemia chart ensures every practitioner uses the same threshold definitions and differential diagnosis logic.

Benefits for your practice

A structured anemia chart delivers measurable operational and clinical benefits:

  • Diagnostic accuracy —Consolidating MCV, RDW, ferritin, TIBC, and reticulocyte interpretation into one visual reference reduces cognitive load and the risk of misclassification. Practitioners apply the same logic every time, reducing variability across the practice.
  • Faster workup decisions —Instead of consulting multiple resources, clinicians reference a single chart to determine next-step testing (B12 level, peripheral smear, Coombs test) and narrow differential diagnoses within minutes. This accelerates patient triage and enables quicker treatment initiation.
  • Compliance with WHO standards —The chart embeds WHO hemoglobin thresholds and severity grading, ensuring all practitioners follow internationally recognized diagnostic criteria. This is essential for multi-location practices and facilities subject to audit or accreditation review.
  • Teaching and training tool —New clinical staff and rotating practitioners reference the chart to understand your practice’s diagnostic approach. It standardizes knowledge transfer and reduces onboarding time for team members unfamiliar with anemia workup protocols.
  • Documentation support —When combined with digital intake forms and assessments, an anemia chart becomes part of a HIPAA-compliant clinical documentation system. Lab results, clinical interpretation, and treatment decisions are captured and linked to patient records systematically.

Pro Tip

Flag patients with elevated RDW (>14.5%) alongside normal MCV for follow-up: mixed causes of anemia (e.g., early iron deficiency plus B12 deficiency) may present with normocytic indices but abnormal RDW. Repeat testing in 4-6 weeks if the initial workup is inconclusive.

Anemia classification by morphology and severity

The morphologic approach to anemia—classifying cases as microcytic, normocytic, or macrocytic based on MCV—remains the gold standard for differential diagnosis. Each category maps to a distinct set of etiologies and next-step investigations.

  • Microcytic anemia (MCV <80 fL) —Common causes include iron deficiency, thalassemia trait, and anemia of chronic disease. Low ferritin confirms iron deficiency, and elevated TIBC supports it; normal-to-high ferritin with low TIBC instead suggests anemia of chronic disease (AOCD) or chronic inflammation. Key lab markers: serum ferritin, TIBC, serum iron, peripheral smear for target cells.
  • Normocytic anemia (MCV 80-100 fL) —Etiologies range from acute blood loss and hemolytic anemia to bone marrow disorders and renal disease. Check reticulocyte count: elevated suggests hemolysis or acute bleeding; low suggests bone marrow failure or renal insufficiency. Follow-up tests: haptoglobin, LDH, Coombs test, renal function (creatinine, BUN), EPO level.
  • Macrocytic anemia (MCV >100 fL) —Most commonly caused by vitamin B12 or folate deficiency (megaloblastic) or alcohol-related bone marrow suppression (non-megaloblastic). Obtain serum B12 and folate levels; if both are low, investigate cause (pernicious anemia, dietary insufficiency, malabsorption). Peripheral smear shows hypersegmented neutrophils in megaloblastic anemia.

WHO severity grading overlays hemoglobin thresholds onto this morphologic framework. Mild anemia (hemoglobin 11.0-11.9 g/dL in non-pregnant females, 11.0-12.9 g/dL in males) may be managed with outpatient workup and supplementation; moderate anemia (8.0-10.9 g/dL) warrants closer investigation; severe anemia (<8.0 g/dL) requires prompt intervention, likely referral or hospitalization, and consideration of transfusion if the patient is symptomatic. An integrated anemia chart displays all three dimensions—morphology, severity, and etiology—in a single reference format.

Lab values and interpretation reference

Anemia workup relies on a constellation of laboratory markers. Understanding normal ranges and clinical significance prevents misinterpretation and guides targeted follow-up.

Lab MarkerNormal RangeClinical Significance in Anemia
Hemoglobin (Hgb)Adult M: 13-16 g/dL; Adult F: 12-15 g/dLPrimary diagnostic criterion; values below WHO thresholds confirm anemia presence and severity grade.
Mean Corpuscular Volume (MCV)80-100 fLClassifies anemia morphologically; directs differential diagnosis pathway (microcytic, normocytic, macrocytic).
Red Cell Distribution Width (RDW)11.5-14.5%Measures RBC size variation; elevated RDW suggests mixed causes or early deficiency; helps differentiate iron deficiency from thalassemia.
Reticulocyte Count0.5-2%Indicates bone marrow response; elevated suggests hemolysis or acute bleeding; low suggests production defect (iron, B12, folate, bone marrow disorder).
Serum Ferritin12-150 ng/mL (F); 24-300 ng/mL (M)Reflects iron stores; low (<15 ng/mL) confirms iron deficiency; elevated may indicate chronic disease or hemochromatosis.
Total Iron-Binding Capacity (TIBC)250-425 mcg/dLMeasures transferrin availability; elevated TIBC with low ferritin confirms iron deficiency; low TIBC with normal-to-high ferritin suggests AOCD.
Serum B12200-900 pg/mLConfirms B12 deficiency in macrocytic anemia; levels 200-400 may indicate early deficiency requiring methylmalonic acid and homocysteine testing.
Serum Folate>5.4 ng/mLAssesses folate status; low folate (along with elevated homocysteine) confirms folate deficiency as cause of macrocytic anemia.

Note: Reference ranges vary slightly between laboratories. Always reference your facility’s specific range when interpreting results. For functional medicine practitioners, optimizing these ranges (e.g., ferritin 30-100 ng/mL for symptom resolution) may extend beyond standard clinical thresholds.

Supporting anemia workup in your practice

Implementing an anemia chart in routine practice requires more than printing a reference—it requires integration into practice workflows, staff training, and patient communication protocols.

Distribute the chart to all clinical staff and include it in new-hire orientation. Conduct a brief training session explaining the morphologic classification logic and how to use the chart to guide test ordering and clinical documentation. Make the chart visible in consultation rooms or break rooms so practitioners reference it during patient visits. Link the chart to your WHO guidelines and ARUP’s anemia testing algorithm as authoritative references for your team.

For practices managing multi-location teams or practitioners across different settings, embedding the anemia chart into AI-powered clinical documentation systems ensures consistent interpretation. When practitioners document anemia findings in a structured format—MCV category, hemoglobin severity, next-step test recommendations—the system can flag missing differential diagnoses or incomplete workups, supporting diagnostic accuracy across the entire practice.

AI powered patient letters
AI powered patient letters

Conclusion

An anemia chart transforms blood work interpretation from a time-consuming differential diagnosis into a rapid, systematic process. By consolidating morphologic classification, WHO severity thresholds, key lab markers, and diagnostic pathways into a single reference, the chart enables clinicians to move from lab results to treatment decisions confidently. Whether your practice specializes in medical spa and aesthetic practitioners screening for anemia before IV therapy or primary care practices managing chronic disease anemia, a well-designed chart reduces diagnostic variability and accelerates patient care. Download the template above and integrate it into your team’s standard protocols today—see how Pabau helps organize clinical workflows and ensure every test result connects to documented clinical reasoning.

Continue your research

Continue your research

Need a framework for blood work interpretation? Interpreting Biomarkers Without Overpromising provides practical guidance on translating lab results into clinically meaningful patient conversations.

Looking to standardize clinical documentation? Safer Clinical Notes outlines best practices for documenting anemia findings and diagnostic reasoning in patient records.

Want to scale anemia protocols across your team? Paperless Clinical Workflows shows how integrated clinical documentation systems support consistent diagnostic protocols across multiple practitioners and locations.

Frequently asked questions

What is an anemia chart?

An anemia chart is a diagnostic reference tool that classifies anemia by morphology (microcytic, normocytic, macrocytic), hemoglobin severity, and key lab values (MCV, RDW, ferritin, TIBC, reticulocyte count) to guide differential diagnosis and treatment decisions in clinical practice.

What are the 3 types of anemia by MCV?

Microcytic anemia (MCV <80 fL, common causes: iron deficiency, thalassemia), normocytic anemia (MCV 80-100 fL, causes: hemolysis, acute bleeding, renal disease), and macrocytic anemia (MCV >100 fL, causes: B12 or folate deficiency, alcohol-related bone marrow suppression).

What lab values indicate anemia?

Hemoglobin below WHO thresholds (13 g/dL in adult males, 12 g/dL in non-pregnant adult females) confirms anemia. MCV determines morphologic classification; RDW (normal 11.5-14.5%) and reticulocyte count (normal 0.5-2%) help differentiate causes and assess bone marrow response.

How do you differentiate types of anemia on a blood smear?

Microcytic anemia shows small, hypochromic RBCs; target cells suggest thalassemia. Normocytic anemia with spherocytes and elevated bilirubin suggests hemolytic anemia. Macrocytic anemia displays hypersegmented neutrophils (B12 deficiency) or macroovalocytes. Peripheral smear results confirm lab-based classification and narrow differential diagnosis.

What is normal hemoglobin range?

Normal hemoglobin is 13-16 g/dL in adult males and 12-15 g/dL in non-pregnant adult females. WHO defines anemia as hemoglobin below 13 g/dL in males and below 12 g/dL in non-pregnant females. Pediatric and pregnant thresholds differ and should be referenced separately.

How often should anemia be rechecked?

After initial diagnosis and treatment initiation, recheck hemoglobin in 4-6 weeks for iron supplementation, 8-12 weeks for B12 or folate replacement. For chronic disease anemia, monitor every 3 months. Acute bleeding or hemolytic episodes warrant urgent rechecking. Always reference your practice’s protocols and the patient’s clinical response to guide timing.

×